Petlife Pharmaceuticals Inc Share Price Other OTC
Equities
US71639B1052
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
2018 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
Sales 2016 | - | Sales 2017 | - | Capitalization | 8.69M 725M |
---|---|---|---|---|---|
Net income 2016 | -3M -250M | Net income 2017 | -23M -1.92B | EV / Sales 2016 | - |
Net Debt 2016 | 0.16 13.5 | Net Debt 2017 | 0.66 55.29 | EV / Sales 2017 | - |
P/E ratio 2016 |
-1.86
x | P/E ratio 2017 |
-0.37
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 30/18/30 | |
Vivek Ramana
CTO | Chief Tech/Sci/R&D Officer | 65 | 30/16/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 30/18/30 |
1st Jan change | Capi. | |
---|---|---|
+25.57% | 661B | |
+26.74% | 566B | |
-6.74% | 352B | |
+18.80% | 332B | |
+3.20% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.45% | 145B |